PHARMACO-VIGILANCE.EU KEYWORD DENSITY CHECKER

Total words: 1598 | 2-word phrases: 413 | 3-word phrases: 442 | 4-word phrases: 452

PAGE INFO

Title Try to keep the title under 60 characters (20 characters)
Pharmaco Vigilance |
Description Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (18 characters)
Pharmaco Vigilance

ONE WORD PHRASES 291 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1the217.22%
2of165.50%
3in134.47%
42024113.78%
5june113.78%
6cadth93.09%
7and82.75%
8to82.75%
9de62.06%
10archive62.06%

TWO WORD PHRASES 413 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1june 2024112.66%
22024 cadth92.18%
3in the40.97%
4of drugs30.73%
5case reports30.73%
6the patient20.48%
7cadth le20.48%
8increase in20.48%
9dans le20.48%
10le traitement20.48%
11and the20.48%
12from the20.48%
13traitement de20.48%
14de la20.48%
15on the20.48%
1620 june20.48%
17to the20.48%
18archive focus20.48%
19more archive20.48%
20focus on20.48%

THREE WORD PHRASES 442 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1june 2024 cadth92.04%
2le traitement de20.45%
3review and deprescribing20.45%
42024 cadth le20.45%
520 june 202420.45%
6dans le traitement20.45%
7traitement de la20.45%
8cyclique et du10.23%
9la prise en10.23%
10effets toxiques liés10.23%
11des effets toxiques10.23%
12charge des effets10.23%
13en charge des10.23%
14de la sclérose10.23%
15prise en charge10.23%
16en plaques cyclique10.23%
17et du syndrome10.23%
18dans la prise10.23%
19l’infliximab dans la10.23%
20toxiques liés aux10.23%
21plaques cyclique et10.23%
22isolé 14 june10.23%
23clinique isolé 1410.23%
24syndrome clinique isolé10.23%
25du syndrome clinique10.23%
2614 june 202410.23%
27skip to main10.23%
28traitements par des10.23%
29non cancéreuse link10.23%
30two stories the10.23%

FOUR WORD PHRASES 452 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1le traitement de la20.44%
220 june 2024 cadth20.44%
3june 2024 cadth le20.44%
4dans le traitement de20.44%
5en plaques cyclique et10.22%
6isolé 14 june 202410.22%
7clinique isolé 14 june10.22%
8syndrome clinique isolé 1410.22%
9du syndrome clinique isolé10.22%
10et du syndrome clinique10.22%
11cyclique et du syndrome10.22%
12plaques cyclique et du10.22%
13skip to main content10.22%
14traitement de la sclérose10.22%
15l’infliximab dans la prise10.22%
16minocycline dans le traitement10.22%
17la minocycline dans le10.22%
18et la minocycline dans10.22%
19glatiramère et la minocycline10.22%
20de glatiramère et la10.22%
21cadth les interférons l’acétate10.22%
222024 cadth les interférons10.22%
2314 june 2024 cadth10.22%
24la prise en charge10.22%
25dans la prise en10.22%
26points de contrôle immunitaire10.22%
27non cancéreuse link front10.22%
28de la douleur chronique10.22%
29traitement de la douleur10.22%
30nabilone dans le traitement10.22%
31le nabilone dans le10.22%
32cadth le nabilone dans10.22%
332024 cadth le nabilone10.22%
34de contrôle immunitaire 1410.22%
35de points de contrôle10.22%
3617 june 2024 cadth10.22%
37inhibiteurs de points de10.22%
38des inhibiteurs de points10.22%
39par des inhibiteurs de10.22%
40traitements par des inhibiteurs10.22%

EXTERNAL LINKS

# URL Whois Check
1https://www.farmacovigilanza.eu Whoisfarmacovigilanza.eu
2 http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/glenmark-pharmaceuticals-inc-usa-issues-voluntary-nationwide-recall-potassium-chloride-extended Whoisfda.gov
3 https://www.cadth.ca/fr/clascoterone-0 Whoiscadth.ca
4 https://www.cadth.ca/fr/blinatumomab Whoiscadth.ca
5 https://www.cadth.ca/test-0 Whoiscadth.ca
6 https://www.cadth.ca/fr/donanemab Whoiscadth.ca
7 https://www.cadth.ca/fr/cancer-de-lestomac Whoiscadth.ca
8 https://www.cadth.ca/fr/la-supplementation-en-choline-chez-les-nourrissons-les-enfants-et-les-personnes-enceintes Whoiscadth.ca
9 https://www.cadth.ca/fr/les-interferons-lacetate-de-glatiramere-et-la-minocycline-dans-le-traitement-de-la-sclerose-en Whoiscadth.ca
10 https://www.cadth.ca/fr/linfliximab-dans-la-prise-en-charge-des-effets-toxiques-lies-aux-traitements-par-des-inhibiteurs-de Whoiscadth.ca
11 https://www.cadth.ca/fr/le-nabilone-dans-le-traitement-de-la-douleur-chronique-non-cancereuse Whoiscadth.ca
12 https://jamanetwork.com/journals/jama/article-abstract/2814249 Whoisjamanetwork.com
13 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869307/ Whoisnih.gov
14 https://link.springer.com/article/10.1007/s40264-023-01284-6 Whoisspringer.com
15 http://www.australianprescriber.com Whoisaustralianprescriber.com

Pharmaco-vigilance.eu

Thelancet.com

Allaboutpharmacovigilance.org

Bclplaw.com

Imf.org

Nytimes.com

Lemonde.fr

Ccrps.org

Pharmacovigilancefoundations.com

Gettyimages.com

Creativecommons.org

Email Tools

Bulk Email Verifier

Email Extractor

Extract Email From Domain

Extract Email From Website, Url

Extract Email From Text

Extract Domain From Email List

Website Tools

Link Extractor

Download Youtube Shorts

QR Code Generator